Breast Cancer Res Treat 174 (3): 719-729, 2019.[PUBMED Abstract] Turner NC, Ro J, Andr√© F, et al.: Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.
N Engl J Med 373 (3): 209-19, 2015.[PUBMED Abstract] Verma S, O'Shaughnessy J, Burris HA, et al.: Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2.
Breast Cancer Res Treat 170 (3): 535-545, 2018.[PUBMED Abstract] Janni W, Alba E, Bachelot T, et al.: First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.